3D Medicines Inc

01244

Company Profile

  • Business description

    3D Medicines Inc is a commercial-stage biopharmaceutical company engaged in the research and development of oncology therapies for cancer patients, especially those who require long-term care. It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life. It generates all of its revenue from China.

  • Contact

    No. 3 and No. 5, Laiyang Road
    Shandong
    Qingdao
    CHN

    https://www.3d-medicines.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    191

Stocks News & Analysis

stocks

10 best US dividend aristocrats to buy now—including a surprise outperformer

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks

Leading ASX players in this field look materially overvalued

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.
stocks

After earnings, is Alphabet stock a buy, a sell, or fairly valued?

With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,995.8019.60-0.22%
CAC 407,861.964.600.06%
DAX 4024,262.2244.850.19%
Dow JONES (US)44,461.28171.71-0.38%
FTSE 1009,136.940.620.01%
HKSE24,799.91377.02-1.50%
NASDAQ21,129.6731.380.15%
Nikkei 22541,102.12447.421.10%
NZX 50 Index12,823.7432.23-0.25%
S&P 5006,362.907.96-0.12%
S&P/ASX 2008,740.2016.20-0.19%
SSE Composite Index3,580.9834.73-0.96%

Market Movers